(Q33397115)

26 July 2017

Age-related penetrance of hereditary atypical hemolytic uremic syndrome (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

1 reference

Charis Eng

21

0 references

author name string

Maren Sullivan

1

1 reference

26 July 2017

Lisa A Rybicki

2

1 reference

26 July 2017

Aurelia Winter

3

1 reference

26 July 2017

Michael M Hoffmann

4

1 reference

26 July 2017

Stefanie Reiermann

5

1 reference

26 July 2017

Hannah Linke

6

1 reference

26 July 2017

Klaus Arbeiter

7

1 reference

26 July 2017

Ludwig Patzer

8

1 reference

26 July 2017

Klemens Budde

9

1 reference

26 July 2017

Bernd Hoppe

10

1 reference

26 July 2017

Martin Zeier

11

1 reference

26 July 2017

Karl Lhotta

12

1 reference

26 July 2017

Andreas Bock

13

1 reference

26 July 2017

Thorsten Wiech

14

1 reference

26 July 2017

Ariana Gaspert

15

1 reference

26 July 2017

Thomas Fehr

16

1 reference

26 July 2017

Magdalena Woznowski

17

1 reference

26 July 2017

Gani Berisha

18

1 reference

26 July 2017

Angelica Malinoc

19

1 reference

26 July 2017

Oemer-Necmi Goek

20

1 reference

26 July 2017

Hartmut P H Neumann

22

1 reference

26 July 2017

language of work or name

English

0 references

publication date

12 September 2011

1 reference

26 July 2017

Annals of Human Genetics

1 reference

26 July 2017

75

1 reference

26 July 2017

6

1 reference

26 July 2017

639-647

1 reference

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Thrombomodulin mutations in atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Mendelian genetics of rare--and not so rare--cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Complement regulatory genes and hemolytic uremic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Familial haemolytic uraemic syndrome and an MCP mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

The molecular basis of hereditary complement factor I deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

Thrombotic microangiopathies: new insights and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-1809.2011.00671.X

10.1111/J.1469-1809.2011.00671.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference